Adherence to denosumab therapy and fracture risk associated with drug withdrawal: a retrospective study
Our findings suggest that some fractures after denosumab discontinuation may stem from the natural progression of osteoporosis rather than from the rebound effect. Still, unscheduled treatment discontinuation should be prevented.
Authors
- Filiz Tuna (ORCID: https://orcid.org/0000-0002-9563-8028)
- Derya Demirbağ Kabayel (ORCID: https://orcid.org/0000-0003-1974-8054)
- Selçuk Korkmaz (ORCID: https://orcid.org/0000-0003-4632-6850)
- Hande Özdemir (ORCID: https://orcid.org/0000-0002-1717-9604)
- Buket Yılmaz Bülbül (ORCID: https://orcid.org/0000-0003-2651-0036)
- Mehmet Çelik (ORCID: https://orcid.org/0000-0001-7364-370X)
- Nur Kakilli
Institutions
- Trakya University (TR)
Publication Details
- Journal
- Croatian Medical Journal
- Published
- 2025-10-01
- DOI
- https://doi.org/10.3325/cmj.2025.66.334
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Trakya Üniversitesi